Introduction

1
Sepsis is a leading cause of mortality in critical care worldwide. [1] [2] [3] In addition to mortality, sepsis 2 may also induce acute organ dysfunction, and even cause long-term post-sepsis cardiovascular 3 diseases.
[4] The reported incidence of sepsis varies; however, it presents an undoubtedly 4 increasing trend that is reflected in the aging population and greater recognition of this condition. 5
Treating sepsis patients causes significant national financial burdens. 6 Diabetes is an important comorbid condition in sepsis because of its high prevalence.
[5] It has 7 generally been believed that diabetic patients are more prone to infections than the general 8 population. [6] However, the influence of diabetes on the outcome of sepsis remains inconclusive. 9
Higher mortality rates in the patients with diabetes were reported [7] [8] [9] [10] [11] [12] ; however, some others 10 found no influence [13] [14] [15] [16] , and even protective effects of diabetes in sepsis. [17] [18] [19] [20] 11
The most frequently proposed study limitations of this debate were the study designs: the 12 epidemiological studies using large cohorts can avoid the selection bias that is frequently observed 13 in hospital-based studies, however, detailed clinical information is usually not available. Most 14 importantly, many studies failed to consider the influence of diabetic complication severity. 15
HbA1c is commonly used to measure blood glucose control in diabetic patients and has also 16 been proposed as an independent predictor for hospital mortality in sepsis patients.
[21] However, 17 its importance in diabetic sepsis patients requires further study due to limited information. 18 Hyperglycemia was shown to impair polymorphonuclear neutrophil function and cytokine 19 production. However, it was reported that high initial glucose levels were not associated with 20 increased mortality in the diabetic sepsis patients. [22] Furthermore, tight glucose control did not 21 seem to be significantly associated with reduced hospital mortality in critical patients. [23, 24] The 22 influence of HbA1c and initial glucose levels on the outcome of sepsis deserves further 23 investigation. 24
In the current study, using the representative nationwide database and the hospital-based 25 database from multi-centers with laboratory data, we examined the association between type 2 26 diabetes and sepsis outcomes, and specifically focused on (1) whether diabetes itself increases the 27 risk of mortality in hospitalized sepsis patients or depends on the diabetes complication burdens 28 and (2) whether initial blood glucose levels and HbA1c affect the hospital course and outcomes. 29
Methods
1
Data sources and study participants 2
Nationwide database 3
In the first part of this study, we conducted a nationwide cohort study using data from the 4 National Health Insurance Research Database (NHIRD). The diagnosis codes of the International 5
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) are used in the NHIRD 6 to identify specific diagnoses. Sepsis patients were retrieved using the ICD-9-CM codes 038. The 7 specificity of a sepsis diagnosis in the NHIRD has been validated in previous studies. [ The patients were classified as using certain drugs if they took them for more than one month 10 within a one-year period prior to the index hospitalization. The index date was defined as the first 11 date of index hospitalization. The drug codes are shown in Supplement Table 2 . The procedures 12 during hospitalization were defined by using the claims data (Supplement Table 3 ). 13
Initially, we used the Longitudinal Cohort of Diabetes Patients (LHDB) of the NHIRD, which 14 contains randomized selected data (120,000 patients / year) from patients with newly diagnosed 15 diabetes to retrieve the study cohort of type 2 diabetic first episode sepsis patients.
[27] The 16 patients in the study cohort should have been diagnosed to have type 2 diabetes prior to the index 17 hospitalization to allow for the evaluation of diabetic complication status by using the adapted 18 Diabetes Complications Severity Index score (aDCSI score) (Supplement Table 4 The participant selection process of the nationwide and hospital-based databases was showed 10 in Supplement Figure 1 and Supplement Figure 2. Only type 2 diabetic patients were included for 11 further study. In the hospital-based database, the initial blood glucose level was obtained on the 12 admission day ether in the emergency department or ward before receiving any acute 13 glucose-lowering injection therapy, that is, insulin; the HbA1c level should be obtained in a period 14 of three days around the admission day. 15
Statistical analyses 16
In the hospital-based database, the type 2 diabetic and non-diabetic sepsis patients were matched 17 by age and gender. In the nationwide database, the study cohort from the LHDB and the 18 comparison cohort from the LHID2000 were matched by the propensity score matching method. 19 For each patient, we calculated the propensity score using the multivariate logistic regression by 20 entering age, gender, income, urbanization level, hospital level, baseline comorbidities, and 21 infection site. 22 Differences in demographic characteristics, comorbidities, medications, and laboratory data 23 were examined using Chi-square, Mann-Whitney and two-sample t-tests. Odds ratios (ORs) with 24 95% confidence intervals (95% CIs) were calculated in the logistic regression model. The 25
Kaplan-Meier analysis with log-rank test was conducted to compare the hospital outcome in 26 patients with different initial blood glucose levels and HbA1c. The statistical analyses were 27 performed using SAS 9.4 statistical package (SAS Institute Inc., Cary, NC, USA). A P value of 0.05 28 was considered significant. 29
31
Sensitivity analysis 1
Because of limited cases with the data of HbA1c using the strict criteria of three days around the 2 admission date, we further conducted a sensitivity analysis. The HbA1c data was re-collected with 3 a wider time period of one month prior to the admission date to re-examine the effect of HbA1c. 4
Results
1
First part: nationwide database 2
From the LHDB and LHID2000 between 1999 and 2012, after propensity score matching, 19,719 3 type 2 diabetic and an equal number of non-diabetic first episode sepsis patients were retrieved as 4 the study and comparison cohorts. The demographic characteristics, comorbidities, medications, 5 infection sites, and received procedures of the study and comparison cohorts were showed in 6 Supplement Table 5 . 7
Before matching, the diabetic sepsis patients had a higher prevalence of genitourinary tract 8 infection (33.65% versus 27.71%) and soft tissue/musculoskeletal system infection related sepsis 9 (5.77% versus 4.54%) (both P<0.0001). Also, the diabetic sepsis patients more frequently received 10 respiratory support (mechanical ventilation: 39.42% versus 38.18%; non-invasive positive pressure 11 ventilation: 7.12% versus 6.75%, both P<0.0001) and emergent dialysis (11.56% versus 8.28%, 12
P<0.0001, respectively). 13
After matching, in the further multivariate analysis, type 2 diabetic sepsis patients had an 14 increased OR of 1.14 (95% confidence level [CI] 1.1-1.19, P<0.0001) for mortality after adjusting 15
for age, gender, insurance premium (as a proxy for household income), urbanization level, and 16 hospital level (Supplement Table 6 ). 17
In the analysis according to diabetic complication burdens, the patients with aDCSI scores of 0, 1, 18 2, 3, 4, and ≥5 had ORs of 0.91 (95% CI, 0.85-0.97), 0.87 (95% CI, 0.8-0.96), 1.14 (95% CI, 19
1.07-1.22), 1.25 (95% CI, 1.13-1.38), 1.56 (95% CI, 1.43-1.7), and 1.77 (95% CI, 1.61-1.96) for 20 mortality during sepsis, respectively (all P<0.001 and P for trend <0.001) (Figure 1 ). In the 21 subgroup analysis stratified by age (every 10 years), the type 2 diabetic sepsis patients with higher 22 aDCSI scores had increased ORs for mortality compared to those with lower scores, particularly in 23 the 30-39 age group (Supplement Figure 3) . In the univariate and further multivariate logistic regression analyses, type 2 diabetes was 6 associated with an increased risk of hospital mortality during the sepsis course (adjusted OR=1.31, 7 95% CI, 1.11-1.54, P=0.002) (Supplement Table 7 ). But the Kaplan-Meier analysis with log-rank test 8 did not show a significant difference of hospital course of mortality between the type 2 diabetic 9 and non-diabetic sepsis patients (P=0.122) (Figure 2A) . 10
The 1,054 type 2 diabetic sepsis patients were divided into surviving and dead groups for 11 further comparison (Supplement Table 8 ). Initial blood glucose levels in the surviving and dead 12 diabetic sepsis patients did not differ significantly: 273.9 ± 180.3 versus 266.1 ± 200.2 (mg/dL) 13 (P=0.095) ( Figure 2B ). Furthermore, the surviving diabetic sepsis patients did not have lower 14
HbA1c (%) than the dead diabetic sepsis patients: 8.4 ± 2.6 versus 8.0 ± 2.5 (P=0.078). In the 15 further logistic regression analysis, the univariate analysis which included age, gender, CCI score 16 and important laboratory data, showed an OR of 1.00 (95% CI, 1.00-1.00, P=0.532) for initial 17 glucose levels and 0.94 (95% CI, 0.86-1.02, P=0.143) for HbA1c (Supplement Table 9 ). The 18
Kaplan-Meier analysis with log-rank test also showed that the hospital mortality during the sepsis 19 course did not differ between type 2 diabetic sepsis patients with different initial blood glucose 20 levels (≤200, 201-400, and >400 mg/dL) and HbA1c (≤7 and >7%) (Figure 3 ) (Supplement Table 10  21 and Supplement Table 11 ). 22 In the sensitivity analysis, using a wider time period of one month prior to the admission date 1 for HbA1c collection, the hospital mortality during the sepsis course between the type 2 diabetic 2 sepsis patients with HbA1c ≤7 and >7% did not differ significantly (47.2% versus 44.3%, P=0.471) 3 (Supplement Table 12 by the lack of severity classification of diabetic complications. In our current study, we introduced 13 the utilization of aDCSI score and the results showed that the sepsis outcomes of diabetic patients 14 were mainly determined by the complication burdens of diabetes. This inference was supported 15 by the dose-responsive effect in the trend test in our study. 16
In this study, we found that the OR for hospital mortality elevated as the aDCSI score increased, 17 and presented in a dose-responsive manner. In the type 2 diabetic sepsis patients with an aDCSI 18 score of ≤ 1 even had a reverse OR for hospital mortality. However, we did not found an obviously 19 shorter disease course of diabetes (from the first diagnosis date of type 2 diabetes to the index 20 hospitalization date) in the patients with an aDCSI score of ≤1 (median duration = 294 days) 21 compared to those with an aDCSI score of >2 (median duration = 306 days). From this result, we 22 can infer that in type 2 diabetic sepsis patients, diabetes-related complication burdens are the 23 major determinant of hospital mortality, but not merely the diabetes itself. 24
HbA1c is a widely used marker that reflects the average glucose level within 120 days. It was 25
reported that HbA1c was a major outcome predictor in diabetic sepsis patients. However, our study demonstrated that a high blood glucose level at admission was not associated 6 with the hospital outcome. 7
Our study has the strengths. We examined the association between type 2 diabetes and sepsis 8 outcomes by concomitantly using the representative nationwide database (LHDB and LHID2000) 9 and the hospital-based database from medical centers (details in the appendix) with laboratory 10 data. Using this method, we longitudinally linked the long-term accumulated diabetic complication 11 burdens, HbA1c (as a representation of recent glucose control), and initial blood glucose levels at 12 admission to describe the complex trajectory of the disease course in these type 2 diabetic sepsis 13 patients. Our study which evaluated the diabetic complication burdens by using aDCSI score rather 14 than simply adjusting for baseline comorbidities was of important innovation in this topic. Also, in 15 this study of the nationwide database, we used the claims data for procedures such as mechanical 16 ventilation, hemodialysis and so on; therefore the accuracy is much better than the use of ICD 17 codes for acute organ dysfunction. Finally, the detailed information such as blood culture results in 18 the hospital-based database provided a richer understanding in the complex interplay between 19 type 2 diabetes and sepsis, rather than simple taxonomy. 20
This study has limitations. First, although we were able to link the individual patient's medical 21 information between the hospital-based database and the nationwide database to create a 22 convincing longitudinal cohort study. However, due to the increasing conflict of health database 23 utilization in Taiwan, we abandoned this idea to avoid further severe conflicts. Second, HbA1c was 24 usually measured at the physician's discretion and we initially included only one third of the whole 25 type 2 diabetic sepsis patients with data of HbA1c (366 in 1054), that might induce a significant 26 bias. We therefore use a wider time period of one month to substitute three days as the inclusion 27 criteria to examine the effect of HbA1c on sepsis outcome. However, the OR of HbA1c and 28 hospitalization course remained unchanged in using the larger sample size (953 in 1054). 29
Conclusion
1
In type 2 diabetic sepsis patients, diabetes-related complication burdens are the major 2 determinant of hospital mortality, rather than the diabetes itself. Initial blood glucose levels and 3
HbA1c may not be associated with the hospital outcome of sepsis. 4
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